Abstract:The HIV-1 protease enzyme is indispensable for viral maturation, making it a major potential target of anti-HIV therapy. Its role is to split newly formed Gag and Gag-Pol polyproteins to produced finished structural and functional proteins — itself included. The early events in the autoprocessing of HIV-1 protease, in which a precursor dimer is thought to undergo intramolecular cleavage, have now been visualized using NMR spectroscopy and paramagnetic relaxation enhancement. This reveals that although primarily monomeric, the protease is also present as transient encounter complexes that occupy a wide range of orientations relative to the mature dimer. The N-terminal region makes transient intra- and intersubunit contacts with the substrate binding site, allowing autocleavage to occur when the correct dimer orientation is sampled by the encounter complex. HIV-1 protease processes the Gag and Gag-Pol polyproteins into mature structural and functional proteins. The mature protease is only active as a dimer, with catalytic residues contributed by each subunit. The precursor of the active protease undergoes 'maturation' via the intramolecular cleavage of a dimeric species, but it is not clear how this cleavage reaction occurs. The early events in N-terminal auto-processing were visualized using NMR spectroscopy, and it was determined that the precursor forms transient, lowly populated dimeric encounter complexes that occupy a wide range of orientations relative to the mature dimer. The N-terminal region makes transient intra- and intersubunit contacts with the substrate binding site, enabling auto-cleavage to occur when the correct dimer orientation is sampled by the encounter complex ensemble. HIV-1 protease processes the Gag and Gag-Pol polyproteins into mature structural and functional proteins, including itself, and is therefore indispensable for viral maturation1,2. The mature protease is active only as a dimer3,4,5 with each subunit contributing catalytic residues6. The full-length transframe region protease precursor appears to be monomeric yet undergoes maturation via intramolecular cleavage of a putative precursor dimer5,7,8,9,10,11, concomitant with the appearance of mature-like catalytic activity7,9. How such intramolecular cleavage can occur when the amino and carboxy termini of the mature protease are part of an intersubunit β-sheet located distal from the active site is unclear. Here we visualize the early events in N-terminal autoprocessing using an inactive mini-precursor with a four-residue N-terminal extension that mimics the transframe region protease precursor5,12. Using paramagnetic relaxation enhancement, a technique that is exquisitely sensitive to the presence of minor species13,14,15,16, we show that the mini-precursor forms highly transient, lowly populated (3–5%) dimeric encounter complexes that involve the mature dimer interface but occupy a wide range of subunit orientations relative to the mature dimer. Furthermore, the occupancy of the mature dimer configuration constitutes a very small fraction of the self-associated species (accounting for the very low enzymatic activity of the protease precursor), and the N-terminal extension makes transient intra- and intersubunit contacts with the substrate binding site and is therefore available for autocleavage when the correct dimer orientation is sampled within the encounter complex ensemble.

Total chemical synthesis of human T-cell leukemia virus type 1 protease via native chemical ligation.

Discovery of Galangin Derivatives as a Potential T-cell Leukemia Virus 1 Protease Inhibitor Through Chemoinformatics Approaches

Total Chemical Synthesis of the Site-Selective Azide-Labeled [I66A]HIV-1 Protease.

Heteromeric Assembled Polypeptidic Artificial Hydrolases with a Six‐Helical Bundle Scaffold

Site-specific Isopeptide Bridge Tethering of Chimeric gp41 N-terminal Heptad Repeat Helical Trimers for the Treatment of HIV-1 Infection

The Human T-cell Leukemia Virus capsid protein is a potential drug target

Distinct stabilization of the human T cell leukemia virus type 1 immature Gag lattice

Visualizing Transient Events in Amino-Terminal Autoprocessing of HIV-1 Protease

De Novo Design of Isopeptide Bond-Tethered Triple-Stranded Coiled Coils with Exceptional Resistance to Unfolding and Proteolysis: Implication for Developing Antiviral Therapeutics

Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA

Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: selective crystallization and formation of a functional catalytic triad in the active site

An Effective Strategy for Recapitulating N-terminal Heptad Repeat Trimers in Enveloped Virus Surface Glycoproteins for Therapeutic Applications.

Insights into the Structural Function of the Complex of HIV-1 Protease with TMC-126: Molecular Dynamics Simulations and Free-Energy Calculations

Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors

Total Chemical Synthesis of Bovine Pancreatic Trypsin Inhibitor by Native Chemical Ligation.

Computational Modeling and Functional Analysis of Herpes Simplex Virus Type-1 Thymidine Kinase and Escherichia Coli Cytosine Deaminase Fusion Protein

HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors

Adding An Artificial Tailanchor To A Peptide-Based Hiv-1 Fusion Inhibitor For Improvement Of Its Potency And Resistance Profile

Creating an Artificial Tail Anchor As a Novel Strategy to Enhance the Potency of Peptide-Based HIV Fusion Inhibitors

Total Chemical Synthesis of N-Myristoylated Hiv-1 Matrix Protein P17: Structural and Mechanistic Implications of P17 Myristoylation

Structural and Functional Characterization of HIV-1 Cell Fusion Inhibitor T20.